Table 1.
Diagnostic criteria of metabolic syndrome
| Category | WHO, 1998 (15) | IDF, 2005 (1) | Original NCEP, 2001 (16,22) | Modified NCEP (23) |
|---|---|---|---|---|
| Insulin resistance | Known diabetes/ IFG/IGT or insulin resistance plus ≥2 criteria from the categories below | – | – | – |
| ≥3 of the criteria from the categories below | ≥3 criteria from the categories below | |||
| Obesity | BMI≥30 kg/m2 or waist-to-hip ratio >0.9 for men and >0.85 for women | Waist circumference ≥94 cm for men and ≥80 cm for women (a prerequisite) plus ≥2 of the criteria from the categories below | Waist circumference >102 cm for men and >88 cm for women | BMI>30 kg/m2 for white persons; >25 kg/m2 for Asian persons |
| Dyslipidemia | TG≥151 mg/dl or HDL-C<34.8 mg/dl for men or <38.7 mg/dl for women | TG ≥151 mg/dl | TG ≥151 mg/dl | TG ≥151 mg/dl |
| Low HDL-C<38.7 mg/dl in men or <50.3 mg/dl in women | Low HDL-C<38.7 mg/dl in men or <50.3 mg/dl in women | Low HDL-C<38.7 mg/dl in men or <50.3 mg/dl in women | ||
| Hypertension | Receiving treatment or BP≥140/90 mmHg | Receiving treatment or BP≥130/85 mmHg | Receiving treatment or BP≥130/85 mmHg | Receiving treatment or BP≥130/85 mmHg |
| Microalbuminuria | Urinary AER≥20 μg/min or ACR≥20 mg/g | |||
| Dysglycemia | FPG≥101 mg/dl | FPG≥101 mg/dl | FPG≥101 mg/dl or receiving treatment for diabetesa |
WHO, World Health Organization; IDF, International Diabetes Federation; NCEP, National Cholesterol Education Program; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; BMI, body mass index; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; AER, albumin excretion rate; ACR, albumin-to-creatinine ratio; FPG, fasting plasma glucose.
a
Insulin or any oral hypoglycemic agent.